Bessemer Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Buy |
926
+6
| +0.7% | +$91 | ﹤0.01% | 1693 |
|
|
2025
Q1 | $14K | Buy |
920
+753
| +451% | +$11.5K | ﹤0.01% | 1658 |
|
|
2024
Q4 | $2K | Hold |
167
| – | – | ﹤0.01% | 2271 |
|
|
2024
Q3 | $2K | Hold |
167
| – | – | ﹤0.01% | 2278 |
|
|
2024
Q2 | $2K | Hold |
167
| – | – | ﹤0.01% | 1973 |
|
|
2024
Q1 | $2K | Hold |
167
| – | – | ﹤0.01% | 1980 |
|
|
2023
Q4 | $2K | Hold |
167
| – | – | ﹤0.01% | 2058 |
|
|
2023
Q3 | $3K | Sell |
167
-1,050
| -86% | -$18.9K | ﹤0.01% | 1907 |
|
|
2023
Q2 | $19K | Buy |
1,217
+1,050
| +629% | +$16.4K | ﹤0.01% | 1533 |
|
|
2023
Q1 | $3K | Hold |
167
| – | – | ﹤0.01% | 1784 |
|
|
2022
Q4 | $3K | Sell |
167
-1,461
| -90% | -$26.2K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $21K | Buy |
1,628
+1,461
| +875% | +$18.8K | ﹤0.01% | 1357 |
|
|
2022
Q2 | $2K | Sell |
167
-3,223
| -95% | -$38.6K | ﹤0.01% | 1769 |
|
|
2022
Q1 | $49K | Sell |
3,390
-581
| -15% | -$8.4K | ﹤0.01% | 1087 |
|
|
2021
Q4 | $54K | Buy |
3,971
+227
| +6% | +$3.09K | ﹤0.01% | 1103 |
|
|
2021
Q3 | $61K | Sell |
3,744
-196
| -5% | -$3.19K | ﹤0.01% | 1021 |
|
|
2021
Q2 | $66K | Buy |
3,940
+550
| +16% | +$9.21K | ﹤0.01% | 1023 |
|
|
2021
Q1 | $62K | Buy |
+3,390
| New | +$62K | ﹤0.01% | 972 |
|
|
2020
Q4 | – | Sell |
-372
| Closed | -$7K | – | 1574 |
|
|
2020
Q3 | $7K | Buy |
+372
| New | +$7K | ﹤0.01% | 1157 |
|
|
2019
Q4 | – | Sell |
-76
| Closed | -$1K | – | 1763 |
|
|
2019
Q3 | $1K | Buy |
76
+31
| +69% | +$408 | ﹤0.01% | 1682 |
|
|
2019
Q2 | $1K | Sell |
45
-352
| -89% | -$7.82K | ﹤0.01% | 1608 |
|
|
2019
Q1 | $8K | Buy |
+397
| New | +$8K | ﹤0.01% | 1539 |
|